Overview

• Zepbound vials will be available for $399 per month, significantly lower than other obesity drugs.
• The initiative aims to ease the ongoing shortage of Zepbound in the U.S.
• Patients must have a valid prescription and purchase through the LillyDirect program.
• Experts commend the move as a step towards more equitable access to weight-loss treatments.
• The program excludes delivery pens and syringes, focusing on affordability and availability.